featured
Long-Term Outcomes With Advanced Melanoma and Initial Stable Disease With Pembrolizumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-term outcomes in patients with advanced melanoma who had initial stable disease with pembrolizumab in KEYNOTE-001 and KEYNOTE-006
Eur. J. Cancer 2021 Nov 01;157(xx)391-402, O Hamid, C Robert, A Daud, MS Carlino, TC Mitchell, P Hersey, J Schachter, GV Long, FS Hodi, JD Wolchok, A Arance, JJ Grob, AM Joshua, JS Weber, L Mortier, E Jensen, SJ Diede, BH Moreno, A RibasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.